Medicare Enrolled

Dr. Alyssa Rieber, M.D.

Hematology & Oncology · Fredericksburg, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
506 W WINDCREST ST STE 300, Fredericksburg, TX 78624
8309900255
In practice since 2006 (19 years)
NPI: 1639265796 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rieber from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rieber? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rieber

Dr. Alyssa Rieber is a hematology & oncology in Fredericksburg, TX, with 19 years in practice. Based on federal Medicare data, Dr. Rieber performed 149,797 Medicare services across 5,307 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rieber received a total of $1,205 from 13 pharmaceutical and/or device companies across 48 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rieber is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 3% volume in TX$ $1,205 industry payments

Medicare Practice Summary

Medicare Utilization ↗
149,797
Medicare services
Top 3% in TX for hematology & oncology
5,307
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7,884 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Darbepoetin injection (Aranesp) for anemia48,830$2$20
Iron infusion (Feraheme)29,070$0$5
Pembrolizumab injection (Keytruda)20,900$43$137
Anti-nausea injection (fosaprepitant)15,450$0$5
Iron sucrose injection (Venofer)11,200$0$2
Immune globulin infusion (Octagam)4,480$33$235
Dexamethasone injection (steroid)3,010$0$1
Injection, granisetron hydrochloride, 100 mcg1,730$0$24
Complete blood count (CBC) with differential1,413$8$36
Blood draw (venipuncture)1,407$8$20
Comprehensive metabolic blood panel1,252$10$64
Anti-nausea injection (Aloxi/palonosetron)1,070$1$114
Immunoglobulin level test763$9$56
Flow cytometry, additional marker735$18$180
Office visit, established patient (30-39 min)602$88$368
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less561$22$157
Administration of chemotherapy into vein, 1 hour or less501$98$707
Lactate dehydrogenase (enzyme) level387$6$31
Office visit, established patient (20-29 min)359$62$250
Measurement of immunoglobulin light chains346$17$60
Ferritin level test (iron stores)318$13$60
Iron level test317$6$27
Iron binding capacity test317$9$35
Office visit, established patient, complex (40-54 min)312$130$496
Injection, zoledronic acid, 1 mg312$6$431
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less280$46$313
Drug injection, under skin or into muscle264$10$96
Injection, diphenhydramine hcl, up to 50 mg187$1$7
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle185$55$211
Beta-2 microglobulin (protein) level173$16$96
Administration of additional new drug or substance into vein, 1 hour or less148$48$344
Administration of chemotherapy into vein, each additional hour136$21$161
Leuprolide acetate (for depot suspension), 7.5 mg135$134$3,675
Reticulated (young) platelet measurement127$35$143
Carcinoembryonic antigen (cea) protein level126$19$99
Uric acid level test123$4$25
Injection of additional new drug or substance into vein123$11$108
Infusion, normal saline solution , 1000 cc121$2$19
Telephone medical discussion with physician, 5-10 minutes105$39$143
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour101$15$100
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries99$91$657
Vitamin B-12 level test93$15$76
Nuclear medicine study from skull base to mid-thigh with ct scan90$1,111$4,802
Unclassified drugs90$1$9
Folic acid level test88$14$73
PSA test (prostate cancer screening)88$18$94
Microscopic examination for white blood cells with manual cell count84$4$22
Complete blood count (CBC), automated84$6$34
Magnesium level test81$7$29
Infusion into a vein for hydration, each additional hour80$10$75
Drawing of blood for a medical problem72$65$264
New patient office visit, complex (60-74 min)71$162$709
Red blood count automated, with additional calculations69$5$26
Telephone medical discussion with physician, 11-20 minutes67$61$231
Phosphate level test62$5$24
Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services60$69$70
Infusion into a vein for hydration, 31-60 minutes54$24$256
Thyroid stimulating hormone (TSH) test51$16$80
Irrigation of implanted venous access drug delivery device49$17$114
Immunologic analysis for detection of tumor antigen, quantitative; ca 12541$20$128
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle40$23$145
New patient office visit (45-59 min)36$102$565
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-332$20$128
Flow cytometry technique for dna or cell analysis, first marker32$55$298
Alpha-fetoprotein (afp) level, serum30$16$102
Injection, alteplase recombinant, 1 mg30$69$211
Protein measurement, serum28$11$99
Immunologic analysis technique on serum (immunofixation)27$22$160
Testosterone (hormone) level, total24$25$143
Haptoglobin (serum protein) level20$11$66
Declotting of central venous tube14$25$121
C-reactive protein test (inflammation marker)12$5$33
New patient office visit (30-44 min)12$68$372
Nuclear medicine study whole body with ct scan11$1,105$4,929
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
23.2% high complexity
69.5% medium
7.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,205
Total received (2018-2024)
Avg $201/year across 6 years
Bottom 33% in TX for hematology & oncology
13
Companies
48
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$715 (59.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$490 (40.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$218
2023
$465
2022
$214
2021
$45
2019
$154
2018
$108

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$287
GENZYME CORPORATION
$166
Gilead Sciences, Inc.
$142
E.R. Squibb & Sons, L.L.C.
$137
Lilly USA, LLC
$125
AstraZeneca Pharmaceuticals LP
$125
Janssen Biotech, Inc.
$70
Apellis Pharmaceuticals, Inc.
$30
Alexion Pharmaceuticals, Inc.
$30
Janssen Pharmaceuticals, Inc
$30
Puma Biotechnology, Inc.
$23
Novartis Pharmaceuticals Corporation
$23
Regeneron Healthcare Solutions, Inc.
$17
Top 3 companies account for 49.4% of total payments
Associated products mentioned in payments ›
DARZALEX · Empaveli · IBRANCE · LIBTAYO · OPDIVO · RETEVMO · SARCLISA · SCEMBLIX · TALZENNA · TECVAYLI · Trodelvy · ULTOMIRIS · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (59%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1 per 100 Medicare services performed
Looking for a hematology & oncology in Fredericksburg?
Compare hematology & oncologys in the Fredericksburg area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
3
Per 100K population
11.0
County median income
$67,799
Nearest hospital
HILL COUNTRY MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rieber is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rieber experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Rieber performed 48,830 darbepoetin injection (aranesp) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rieber receive payments from pharmaceutical companies?
Yes. Dr. Rieber received a total of $1,205 from 13 companies across 48 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rieber's costs compare to other hematology & oncologys in Fredericksburg?
Dr. Rieber's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rieber) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →